DPP10 Antibodies

Santa Cruz Biotechnology offers a broad range of DPP10 monoclonal antibodies for research focused on understanding DPP10's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DPP10, or Dipeptidyl Peptidase 10, belongs to the DPP family and plays a crucial role in regulating the activity of neuropeptides and other bioactive peptides. DPP10 is involved in modulating neuronal excitability and has been linked to various neurological disorders. Research has shown that DPP10 expression patterns vary across different tissues and developmental stages. Understanding DPP10's molecular mechanisms and interactions can provide valuable insights into neurological disease pathways. Investigating DPP10's function may lead to new therapeutic strategies for treating neurological conditions. Current studies continue to reveal new aspects of DPP10's biological significance and potential clinical applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DPP10 and its role in human health and disease.